Press Releases, Pharmaceutical

Aptar Pharma Discusses with Forbes its Expanded Partnership with Propeller Health to Deliver Connected Medicines

Aptar Pharma Discusses with Forbes its Expanded Partnership with Propeller Health to Deliver Connected Medicines

31 May 2018

A recent article on Forbes.com discusses the significance of Aptar Pharma’s expanded relationship with Propeller Health to deliver Connected Medicines across multiple therapeutic areas. Announced May 30, this partnership, which includes a strategic equity investment by Aptar Pharma in Propeller Health, is “a move that signals the pharmaceutical industry’s growing interest in digital therapeutics.”
To find out more, read the full article: https://bit.ly/2xvfwxS

Back To Top